{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T16:34:18Z","timestamp":1795019658716,"version":"4.10.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82274218"],"award-info":[{"award-number":["82274218"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Vascular dementia (VaD) is a neurodegenerative disease primarily characterized by white matter injury and myelin degeneration, and currently, there is a lack of effective treatment options. This study aims to investigate the effects of the traditional Chinese medicine formula Danggui Shaoyao San (DSS) on cognitive function and myelin repair in VaD rats and to elucidate its underlying mechanisms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The VaD rat model was established using the bilateral common carotid artery ligation (2VO) method. The effects of DSS on cognitive function, myelin regeneration, sphingolipid metabolism, and SPHK2\/S1P\/S1PR5 pathway was conducted using behavioral tests, histological staining, Western blot, lipidomics, qPCR, immunofluorescence, LC\u2013MS\/MS, and 16S rRNA sequencing. Besides, molecular docking and molecular dynamics simulation were carried out.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>DSS treatment significantly improved learning and memory abilities in VaD rats, reduced structural damage in the hippocampus and white matter, and promoted the differentiation of oligodendrocyte precursor cells (OPCs) into mature oligodendrocytes (OLs). Lipidomics and molecular biological experiments indicated that DSS activated the SPHK2\/S1P\/S1PR5 pathway, ameliorated sphingolipid metabolic disorders and increased S1P levels, thereby promoting myelin repair. The specific SPHK2 inhibitor ABC294640 significantly weakened the neuroprotective effects of DSS, further confirming the central role of SPHK2\/S1P\/S1PR5 pathway. Antibiotic depletion experiments confirmed that the gut microbiota was not a key mediator of the therapeutic effects of DSS. Finally, molecular docking and molecular dynamics simulations indicated that the DSS components Albiflorin and Gallic acid form tighter and more stable interactions with SPHK2.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>DSS improved VaD cognitive impairment by modulating sphingolipid metabolism and promote myelin regeneration via activating the SPHK2\/S1P\/S1PR5 signaling pathway. This study provides important experimental evidence for the clinical application of DSS in VaD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13020-025-01284-x","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T02:02:00Z","timestamp":1767751320000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Danggui-Shaoyao-San modulates sphingolipid metabolism to promote oligodendrocyte differentiation and maturation in vascular dementia rats"],"prefix":"10.1186","volume":"21","author":[{"given":"Yue","family":"Su","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuying","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningning","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengmeng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yafeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,7]]},"reference":[{"key":"1284_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2021.105864","volume":"30","author":"SC Bir","year":"2021","unstructured":"Bir SC, Khan MW, Javalkar V, Toledo EG, Kelley RE. Emerging concepts in vascular dementia: a review. J Stroke Cerebrovasc Dis. 2021;30:105864.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"1284_CR2","volume":"3","author":"S Agrawal","year":"2022","unstructured":"Agrawal S, Schneider JA. Vascular pathology and pathogenesis of cognitive impairment and dementia in older adults. Cereb Circ - Cognit Behavior. 2022;3:100148.","journal-title":"Cereb Circ - Cognit Behavior"},{"key":"1284_CR3","doi-asserted-by":"publisher","first-page":"3326","DOI":"10.1016\/j.jacc.2019.04.034","volume":"73","author":"C Iadecola","year":"2019","unstructured":"Iadecola C, Duering M, Hachinski MDV, Joutel A, Pendlebury ST, Schneider JA, et al. Vascular cognitive impairment and dementia. J Am Coll Cardiol. 2019;73:3326\u201344.","journal-title":"J Am Coll Cardiol"},{"key":"1284_CR4","doi-asserted-by":"publisher","first-page":"503","DOI":"10.4103\/ijmr.IJMR_1336_17","volume":"149","author":"P Sengupta","year":"2019","unstructured":"Sengupta P, Ganguly J, Pal S, Ghosal M. Pattern of cognitive deficits in vascular dementia. Indian J Med Res. 2019;149:503\u20137.","journal-title":"Indian J Med Res"},{"key":"1284_CR5","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1177\/08919887231195225","volume":"37","author":"J Macoir","year":"2024","unstructured":"Macoir J. Language impairment in vascular dementia: a clinical review. J Geriatr Psychiatry Neurol. 2024;37:87\u201395.","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"1284_CR6","doi-asserted-by":"publisher","first-page":"308","DOI":"10.14336\/AD.2020.0427","volume":"12","author":"H Kuang","year":"2021","unstructured":"Kuang H, Zhou Z-F, Zhu Y-G, Wan Z-K, Yang M-W, Hong F-F, et al. Pharmacological treatment of vascular dementia: a molecular mechanism perspective. Aging Dis. 2021;12:308\u201326.","journal-title":"Aging Dis"},{"key":"1284_CR7","unstructured":"J P, G H, A L, M P, Gc D. Regional contribution of vascular dysfunction in white matter dementia: clinical and neuropathological insights. Frontiers in neurology 2023 https:\/\/pubmed.ncbi.nlm.nih.gov\/37396778\/. Accessed 22 May 2025"},{"key":"1284_CR8","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s00018-024-05222-2","volume":"81","author":"H Khelfaoui","year":"2024","unstructured":"Khelfaoui H, Ibaceta-Gonzalez C, Angulo MC. Functional myelin in cognition and neurodevelopmental disorders. Cell Mol Life Sci. 2024;81:181.","journal-title":"Cell Mol Life Sci"},{"key":"1284_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuroscience.2023.10.018","volume":"538","author":"H Zhang","year":"2024","unstructured":"Zhang H, Yang Y, Zhang J, Huang L, Niu Y, Chen H, et al. Oligodendrocytes play a critical role in white matter damage of vascular dementia. Neuroscience. 2024;538:1\u201310.","journal-title":"Neuroscience"},{"key":"1284_CR10","doi-asserted-by":"publisher","first-page":"7644","DOI":"10.1038\/s41598-018-25898-4","volume":"8","author":"S Shimizu","year":"2018","unstructured":"Shimizu S, Ishino Y, Tohyama M, Miyata S. NDE1 positively regulates oligodendrocyte morphological differentiation. Sci Rep. 2018;8:7644.","journal-title":"Sci Rep"},{"key":"1284_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/biom11071058","volume":"11","author":"I Kalafatakis","year":"2021","unstructured":"Kalafatakis I, Karagogeos D. Oligodendrocytes and microglia: key players in myelin development, damage and repair. Biomolecules. 2021;11:1058.","journal-title":"Biomolecules"},{"key":"1284_CR12","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1111\/cns.13497","volume":"26","author":"D Chen","year":"2020","unstructured":"Chen D, Huang Y, Shi Z, Li J, Zhang Y, Wang K, et al. Demyelinating processes in aging and stroke in the central nervous system and the prospect of treatment strategy. CNS Neurosci Ther. 2020;26:1219\u201329.","journal-title":"CNS Neurosci Ther"},{"key":"1284_CR13","doi-asserted-by":"publisher","first-page":"751","DOI":"10.2174\/1570159X19666210610093658","volume":"20","author":"G Garcia-Martin","year":"2022","unstructured":"Garcia-Martin G, Alcover-Sanchez B, Wandosell F, Cubelos B. Pathways involved in remyelination after cerebral ischemia. Curr Neuropharmacol. 2022;20:751\u201365.","journal-title":"Curr Neuropharmacol"},{"key":"1284_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-024-00742-8","volume":"19","author":"O Zveik","year":"2024","unstructured":"Zveik O, Rechtman A, Ganz T, Vaknin-Dembinsky A. The interplay of inflammation and remyelination: rethinking MS treatment with a focus on oligodendrocyte progenitor cells. Mol Neurodegener. 2024;19:53.","journal-title":"Mol Neurodegener"},{"key":"1284_CR15","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.16228","volume":"169","author":"F Binish","year":"2025","unstructured":"Binish F, Xiao J. Deciphering the role of sphingosine 1\u2010phosphate in central nervous system myelination and repair. J Neurochem. 2025;169:e16228.","journal-title":"J Neurochem"},{"key":"1284_CR16","doi-asserted-by":"publisher","first-page":"430","DOI":"10.14740\/wjon1656","volume":"14","author":"K Moro","year":"2023","unstructured":"Moro K, Ichikawa H, Koyama Y, Abe S, Uchida H, Naruse K, et al. Oral administration of glucosylceramide suppresses tumor growth by affecting the ceramide\/sphingosine-1-phosphate balance in breast cancer tissue. World J Oncol. 2023;14:430\u20137.","journal-title":"World J Oncol"},{"key":"1284_CR17","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.3390\/cells8121573","volume":"8","author":"F Parveen","year":"2019","unstructured":"Parveen F, Bender D, Law S-H, Mishra VK, Chen C-C, Ke L-Y. Role of ceramidases in sphingolipid metabolism and human diseases. Cells. 2019;8:1573.","journal-title":"Cells"},{"key":"1284_CR18","doi-asserted-by":"publisher","first-page":"5436","DOI":"10.1007\/s12035-018-1448-3","volume":"56","author":"K Czubowicz","year":"2019","unstructured":"Czubowicz K, J\u0119\u015bko H, Wencel P, Lukiw WJ, Strosznajder RP. The role of ceramide and sphingosine-1-phosphate in Alzheimer\u2019s disease and other neurodegenerative disorders. Mol Neurobiol. 2019;56:5436\u201355.","journal-title":"Mol Neurobiol"},{"key":"1284_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23147806","volume":"23","author":"C Tringali","year":"2022","unstructured":"Tringali C, Giussani P. Ceramide and sphingosine-1-phosphate in neurodegenerative disorders and their potential involvement in therapy. Int J Mol Sci. 2022;23:7806.","journal-title":"Int J Mol Sci"},{"key":"1284_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20225545","volume":"20","author":"C Sassoli","year":"2019","unstructured":"Sassoli C, Pierucci F, Zecchi-Orlandini S, Meacci E. Sphingosine 1-phosphate (S1P)\/ S1P receptor signaling and mechanotransduction: implications for intrinsic tissue repair\/regeneration. Int J Mol Sci. 2019;20:5545.","journal-title":"Int J Mol Sci"},{"key":"1284_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2024.118306","volume":"331","author":"Y Ningning","year":"2024","unstructured":"Ningning Y, Ying X, Xiang L, Yue S, Zhongda W, Ruoyu J, et al. Danggui-shaoyao san alleviates cognitive impairment via enhancing HIF-1\u03b1\/EPO axis in vascular dementia rats. J Ethnopharmacol. 2024;331:118306.","journal-title":"J Ethnopharmacol"},{"key":"1284_CR22","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1186\/s12906-024-04588-x","volume":"24","author":"X Cheng","year":"2024","unstructured":"Cheng X, Dai Y, Shang B, Zhang S, Lin L, Wu Q, et al. Danggui shaoyao san and disassembled prescription: neuroprotective effects via AMPK\/mTOR-mediated autophagy in mice. BMC Complement Med Ther. 2024;24:298.","journal-title":"BMC Complement Med Ther"},{"key":"1284_CR23","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000018507","volume":"99","author":"Y Kim","year":"2020","unstructured":"Kim Y, Cho S-H. Danggui-shaoyao-san for dementia. Medicine (Baltimore). 2020;99:e18507.","journal-title":"Medicine (Baltimore)"},{"key":"1284_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2024.149135","volume":"1845","author":"X Liu","year":"2024","unstructured":"Liu X, Yao L, Ye X, Qin Y, Chen S, Jiang Q, et al. Danggui-shaoyao-san (DSS) ameliorating cognitive impairment in ischemia\u2013reperfusion vascular dementia mice through miR-124 regulating PI3K\/Akt signaling pathway. Brain Res. 2024;1845:149135.","journal-title":"Brain Res"},{"key":"1284_CR25","doi-asserted-by":"publisher","first-page":"1338804","DOI":"10.3389\/fphar.2023.1338804","volume":"14","author":"J He","year":"2024","unstructured":"He J, Jin Y, He C, Li Z, Yu W, Zhou J, et al. Danggui shaoyao san: comprehensive modulation of the microbiota-gut-brain axis for attenuating Alzheimer\u2019s disease-related pathology. Front Pharmacol. 2024;14:1338804.","journal-title":"Front Pharmacol"},{"key":"1284_CR26","doi-asserted-by":"publisher","first-page":"D368","DOI":"10.1093\/nar\/gkad1011","volume":"52","author":"M Varadi","year":"2023","unstructured":"Varadi M, Bertoni D, Magana P, Paramval U, Pidruchna I, Radhakrishnan M, et al. AlphaFold protein structure database in 2024: providing structure coverage for over 214 million protein sequences. Nucleic Acids Res. 2023;52:D368\u201375.","journal-title":"Nucleic Acids Res"},{"key":"1284_CR27","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70127","volume":"21","author":"J Denecke","year":"2025","unstructured":"Denecke J, Dewenter A, Lee J, Franzmeier N, Valentim C, Kopczak A, et al. Reduced myelin contributes to cognitive impairment in patients with monogenic small vessel disease. Alzheimers Dement. 2025;21:e70127.","journal-title":"Alzheimers Dement"},{"key":"1284_CR28","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.neuroscience.2025.03.002","volume":"572","author":"C Liu","year":"2025","unstructured":"Liu C, Yin H, Chen X, Ban W, Zhu G, Wang J. Electroacupuncture promotes oligodendrocyte differentiation and myelin repair in a rat model of vascular dementia: investigation of the mechanism from NF-\u03baB-mediated inflammation. Neuroscience. 2025;572:21\u201334.","journal-title":"Neuroscience"},{"key":"1284_CR29","doi-asserted-by":"publisher","first-page":"1588375","DOI":"10.3389\/fphar.2025.1588375","volume":"16","author":"K Gong","year":"2025","unstructured":"Gong K, Zhou S, Xiao L, Xu M, Zhou Y, Lu K, et al. Danggui shaoyao san ameliorates Alzheimer\u2019s disease by regulating lipid metabolism and inhibiting neuronal ferroptosis through the AMPK\/Sp1\/ACSL4 signaling pathway. Front Pharmacol. 2025;16:1588375.","journal-title":"Front Pharmacol"},{"key":"1284_CR30","doi-asserted-by":"publisher","first-page":"503","DOI":"10.3390\/molecules25030503","volume":"25","author":"L Lorenzini","year":"2020","unstructured":"Lorenzini L, Fernandez M, Baldassarro VA, Bighinati A, Giuliani A, Calz\u00e0 L, et al. White matter and neuroprotection in Alzheimer\u2019s dementia. Molecules. 2020;25:503.","journal-title":"Molecules"},{"key":"1284_CR31","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adk3931","volume":"10","author":"Y Li","year":"2024","unstructured":"Li Y, Wan LP, Song N-N, Ding Y-Q, Zhao S, Niu J, et al. RNF220-mediated K63-linked polyubiquitination stabilizes Olig proteins during oligodendroglial development and myelination. Sci Adv. 2024;10:eadk3931.","journal-title":"Sci Adv"},{"key":"1284_CR32","doi-asserted-by":"publisher","first-page":"4754","DOI":"10.1038\/s41380-022-01701-9","volume":"27","author":"X Chen","year":"2022","unstructured":"Chen X, Chen L, Lin G, Wang Z, Kodali MC, Li M, et al. White matter damage as a consequence of vascular dysfunction in a spontaneous mouse model of chronic mild chronic hypoperfusion with eNOS deficiency. Mol Psychiatry. 2022;27:4754\u201369.","journal-title":"Mol Psychiatry"},{"key":"1284_CR33","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1002\/acn3.51730","volume":"10","author":"KA Walker","year":"2023","unstructured":"Walker KA, Duggan MR, Gong Z, Dark HE, Laporte JP, Faulkner ME, et al. MRI and fluid biomarkers reveal determinants of myelin and axonal loss with aging. Ann Clin Transl Neurol. 2023;10:397\u2013407.","journal-title":"Ann Clin Transl Neurol"},{"key":"1284_CR34","doi-asserted-by":"publisher","DOI":"10.1007\/s11357-025-01642-5","author":"I Pappas","year":"2025","unstructured":"Pappas I, Lohman T, Dutt S, Kapoor A, Engstrom AC, Alitin JPM, et al. Cerebral hypoperfusion, brain structural integrity, and cognitive impairment in older APOE4 carriers. GeroScience. 2025. https:\/\/doi.org\/10.1007\/s11357-025-01642-5.","journal-title":"GeroScience"},{"key":"1284_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2025.156396","volume":"138","author":"Q Luo","year":"2025","unstructured":"Luo Q, Li F, Liu X, Yan T, Yang L, Zhu W, et al. Puerarin mitigates cognitive decline and white matter injury via CD36-mediated microglial phagocytosis in chronic cerebral hypoperfusion. Phytomedicine. 2025;138:156396.","journal-title":"Phytomedicine"},{"key":"1284_CR36","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1194\/jlr.RA120000627","volume":"61","author":"DL Davis","year":"2020","unstructured":"Davis DL, Mahawar U, Pope VS, Allegood J, Sato-Bigbee C, Wattenberg BW. Dynamics of sphingolipids and the serine palmitoyltransferase complex in rat oligodendrocytes during myelination. J Lipid Res. 2020;61:505\u201322.","journal-title":"J Lipid Res"},{"key":"1284_CR37","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/jnc.15133","volume":"156","author":"P Giussani","year":"2021","unstructured":"Giussani P, Prinetti A, Tringali C. The role of sphingolipids in myelination and myelin stability and their involvement in childhood and adult demyelinating disorders. J Neurochem. 2021;156:403\u201314.","journal-title":"J Neurochem"},{"key":"1284_CR38","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.TR120000972","volume":"62","author":"MV Simon","year":"2021","unstructured":"Simon MV, Basu SK, Qaladize B, Grambergs R, Rotstein NP, Mandal N. Sphingolipids as critical players in retinal physiology and pathology. J Lipid Res. 2021;62:100037.","journal-title":"J Lipid Res"},{"key":"1284_CR39","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13024-021-00488-7","volume":"16","author":"S Qiu","year":"2021","unstructured":"Qiu S, Palavicini JP, Wang J, Gonzalez NS, He S, Dustin E, et al. Adult-onset CNS myelin sulfatide deficiency is sufficient to cause Alzheimer\u2019s disease-like neuroinflammation and cognitive impairment. Mol Neurodegener. 2021;16:64.","journal-title":"Mol Neurodegener"},{"key":"1284_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115838","volume":"169","author":"X Xu","year":"2023","unstructured":"Xu X, Han Y, Zhu T, Fan F, Wang X, Liu Y, et al. The role of SphK\/S1P\/S1PR signaling pathway in bone metabolism. Biomed Pharmacother. 2023;169:115838.","journal-title":"Biomed Pharmacother"},{"key":"1284_CR41","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1007\/s40265-021-01528-8","volume":"81","author":"T P\u00e9rez-Jeldres","year":"2021","unstructured":"P\u00e9rez-Jeldres T, Alvarez-Lobos M, Rivera-Nieves J. Targeting sphingosine-1-phosphate signaling in immune-mediated diseases: beyond multiple sclerosis. Drugs. 2021;81:985\u20131002.","journal-title":"Drugs"},{"key":"1284_CR42","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s12017-020-08614-2","volume":"23","author":"BP Gaire","year":"2021","unstructured":"Gaire BP, Choi JW. Sphingosine 1-phosphate receptors in cerebral ischemia. Neuromol Med. 2021;23:211\u201323.","journal-title":"Neuromol Med"},{"key":"1284_CR43","doi-asserted-by":"publisher","first-page":"5351","DOI":"10.2147\/DDDT.S489860","volume":"18","author":"K Ma","year":"2024","unstructured":"Ma K, An C, Li M, Zhang Y, Ren M, Wei Y, et al. Dexmedetomidine attenuated neuron death, cognitive decline, and anxiety-like behavior by inhibiting CXCL2 in CA1 region of AD mice. Drug Des Devel Ther. 2024;18:5351\u201365.","journal-title":"Drug Des Devel Ther"},{"key":"1284_CR44","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.cmet.2024.01.017","volume":"36","author":"X Ji","year":"2024","unstructured":"Ji X, Chen Z, Wang Q, Li B, Wei Y, Li Y, et al. Sphingolipid metabolism controls mammalian heart regeneration. Cell Metab. 2024;36:839-856.e8.","journal-title":"Cell Metab"},{"key":"1284_CR45","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.3390\/cells9061515","volume":"9","author":"A Lucaciu","year":"2020","unstructured":"Lucaciu A, Brunkhorst R, Pfeilschifter JM, Pfeilschifter W, Subburayalu J. The S1P\u2013S1PR axis in neurological disorders\u2014insights into current and future therapeutic perspectives. Cells. 2020;9:1515.","journal-title":"Cells"},{"key":"1284_CR46","doi-asserted-by":"publisher","first-page":"1289819","DOI":"10.3389\/fmicb.2023.1289819","volume":"14","author":"X Bai","year":"2023","unstructured":"Bai X, Ya R, Tang X, Cai M. Role and interaction of bacterial sphingolipids in human health. Front Microbiol. 2023;14:1289819.","journal-title":"Front Microbiol"},{"key":"1284_CR47","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/j.chom.2022.05.002","volume":"30","author":"HH Le","year":"2022","unstructured":"Le HH, Lee M-T, Besler KR, Johnson EL. Host hepatic metabolism is modulated by gut microbiota\u2013derived sphingolipids. Cell Host Microbe. 2022;30:798-808.e7.","journal-title":"Cell Host Microbe"},{"key":"1284_CR48","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.chom.2019.04.002","volume":"25","author":"EM Brown","year":"2019","unstructured":"Brown EM, Ke X, Hitchcock D, Jeanfavre S, Avila-Pacheco J, Nakata T, et al. Bacteroides-derived sphingolipids are critical for maintaining intestinal homeostasis and symbiosis. Cell Host Microbe. 2019;25:668-680.e7.","journal-title":"Cell Host Microbe"}],"container-title":["Chinese Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-025-01284-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13020-025-01284-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-025-01284-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T02:02:03Z","timestamp":1767751323000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13020-025-01284-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,7]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1284"],"URL":"https:\/\/doi.org\/10.1186\/s13020-025-01284-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7241365\/v1","asserted-by":"object"}]},"ISSN":["1749-8546"],"issn-type":[{"value":"1749-8546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,7]]},"assertion":[{"value":"29 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11"}}